tirzepatide kidney disease (Zepbound) showed improved function in obese patients with both chronic kidney and #heartfailure with preserved ejection fraction, highlighting its potential to address this high-risk patient population. Read more: https Effects of tirzepatide on kidney

Main outcomes measured gene expression differences in liver, jejunal, VAT, and SAT between hyperfilterers and those without hyperfiltration

In the US, points out Thijs Geijer, sector economist for food and agriculture at ING Bank, consumers are more used to paying a lot for drugs, with drug prices frequently being high, although a sizeable share of European households can afford the drugs

91 Skovs, S

Some researchers propose that rapid shifts in pancreatic secretion, bile dynamics, or triglyceride levels might trigger inflammation in vulnerable individuals

Recent Advances in Molecular Pathways and Therapeutic Implications for Peptic Ulcer Management: A Comprehensive Review